Inhibiting DNA-PK induces glioma stem cell differentiation and sensitizes glioblastoma to radiation in mice is a research paper published in Science Translational Medicine (2021). On theSindex it has a DataRank of 0.672. It has been cited 87 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.672
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: S10OD018205
National Institutes of Health
Grant: 1S10RR031537
National Institutes of Health
Grant: NIH R01
National Institutes of Health
Grant: CA184090
National Institutes of Health
Grant: NS091080
National Institutes of Health
Grant: NS099175
NCI NIH HHS
Grant: R01 CA184090
NCRR NIH HHS
Grant: S10 RR031537
NINDS NIH HHS
Grant: R01 NS091080
FUNDING
FWCI
4.49
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of EREG is the core onco-immunological biomarker of cuproptosis and mediates the cross-talk between VEGF and CD99 signaling in glioblastoma
Additional file 1 of EREG is the core onco-immunological biomarker of cuproptosis and mediates the cross-talk between VEGF and CD99 signaling in glioblastoma
Additional file 2 of EREG is the core onco-immunological biomarker of cuproptosis and mediates the cross-talk between VEGF and CD99 signaling in glioblastoma
Additional file 2 of EREG is the core onco-immunological biomarker of cuproptosis and mediates the cross-talk between VEGF and CD99 signaling in glioblastoma